| Trial Name: |
Cancer, Ovarian, Fallopian Tube or Peritoneal
|
| Intro: |
This research study is designed to compare two treatments for ovarian, fallopian tube or peritoneal cancers. |
| Condition: |
|
| Description: |
This research study is designed to compare two treatments for ovarian, fallopian tube or peritoneal cancers. One treatment uses the investigational drug BAY 43-9006 alone. The other treatment uses the experimental drug in combination with two FDA-approved cancer treatment drugs, carboplatin and paclitaxel. Participants have an equal chance of being assigned to either treatment group. |
| Criteria: |
Participants must be at least 18 years of age and must have recurrent, measurable, epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer that is considered platinum sensitive. Participants must have received prior therapy with a platinum-based regimen before study enrollment. Participants must have adequate bone marrow function and must not need an IV to stay hydrated or for nutritional support. Participants of childbearing potential must agree to use adequate contraception. |
| Contact: |
For information or to register for screening in this trial please call HealthMatch at (216) 844-5000, or complete and submit the form below. |
Participant Confidentiality:
All information regarding participation in Clinical Trials is treated with the
utmost confidentiality. University Hospitals Case Medical Center and the
Division of Clinical Research recognize and respect the confidentiality of this
information. Access to information related to clinical trials and their
participants is restricted to authorized clinical trials personnel only.
Back